source Post navigation Boosting Beta Cells to Treat Type 2 Diabetes | Newsroom | Weill … – Weill Cornell Medicine Newsroom FDA Approves Lilly's Zepbound™ (tirzepatide) for Chronic Weight … – Investors | Eli Lilly and Company